KL Acquisition Corp. (KLAQ)
Market Cap | 325.00M |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
Shares Out | 31.25M |
EPS (ttm) | n/a |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 19 |
Last Price | $10.40 |
Previous Close | $10.41 |
Change ($) | -0.01 |
Change (%) | -0.10% |
Day's Open | - |
Day's Range | 10.40 - 10.50 |
Day's Volume | 0 |
52-Week Range | 0.00 - 10.50 |
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- KL Acquisition Corp (NASDAQ: KLAQU) (the "Company") today announced the completion of its initial public offering of 28,750,000 units at a price of $10....
NEW YORK, Jan. 7, 2021 /PRNewswire/ -- KL Acquisition Corp (the "Company") today announced that it priced its initial public offering of 25,000,000 units at $10.00 per unit. The units will be ...
KL Acquisition, a blank check company formed by Kennedy Lewis targeting the healthcare industry, filed on Thursday with the SEC to raise up to $250 million in an initial public offering.
KL Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About KLAQ
KL Acquisition is a blank check company incorporated in August 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Our strategy will be to identify, acquire and, after our initial business combination, build a healthcare or health-related business. We intend to focus our investment effort on life sciences, which includes medical devices, diagnostics and life sciences tools and instrument... [Read more...]
Industry Blank Checks / SPAC | IPO Date Jan 8, 2021 |
CEO Doug Logigian | Country United States |
Stock Exchange NASDAQ | Ticker Symbol KLAQ |